Funding Support (Active)

7. Point-of-care optical spectroscopy platform and novel ratio-metric algorithms for rapid and systematic functional characterization of biological models in vivo

    Funding source: NIDCR R01;   Role: PI;  (Aug 1 2023- July 31 2028)

6. Non-destructive optical spectroscopic assay for high-throughput metabolic characterization of in vitro cell models and patient-derived organoids

    Funding source: NIBIB Trailblazer R21;   Role: PI;  (Aug 1 2022 - March 31 2025)

5. Optical metabolic microscope to study breast cancer radiation biology. 

    Funding source: ACS-IRG;   Role: PI;  (Dec 1 2022 - Nov 30 2023)

4. Optical spectroscopy and microscopy development for translational cancer research.

    Funding source: University of Kentucky Startup;   Role: PI;   (Aug 1 2019 - June 30 2024)

Funding Support (Completed)

3. Optical metabolic imaging on live tumor slices to predict tumor therapy responses. 

    Funding source: University of Kentucky Markey Cancer Center;   Role: PI;  (July 1 2022 - June 30 2023)

2. Intra-vital metabolic microscopy to reveal human cancer radiation resistance mechanism in small animal models

   Funding source: NIH/NIGMS;   Role: COBRE project leader PI;   (Oct 1 2019 - Dec 31 2022)

1. Early prediction of radiation responses for breast cancer patients during the BCS

   Funding source: University of Kentucky IRC;   Role: PI;     (Jan 1 2021 - Dec 31 2021)